Capital Advisors Inc Eli Lilly & CO Transaction History

Capital Advisors Inc

  • $4.61 Billion
  • Q1 2024

A detailed history of Capital Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Advisors Inc holds 4,419 shares of LLY stock, worth $4.01 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,419
Previous 3,953 11.79%
Holding current value
$4.01 Million
Previous $2.3 Million 49.18%
% of portfolio
0.07%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
BUY
$592.2 - $792.28 $275,965 - $369,202
466 Added 11.79%
4,419 $3.44 Million
Q4 2023

Jan 29, 2024
BUY
$525.19 - $619.13 $297,782 - $351,046
567 Added 16.75%
3,953 $2.3 Million
Q3 2023

Oct 24, 2023
BUY
$434.7 - $599.3 $46,947 - $64,724
108 Added 3.29%
3,386 $1.82 Million
Q2 2023

Jul 18, 2023
BUY
$350.74 - $468.98 $144,504 - $193,219
412 Added 14.38%
3,278 $1.54 Million
Q1 2023

Apr 19, 2023
BUY
$310.63 - $364.82 $22,675 - $26,631
73 Added 2.61%
2,866 $984,000
Q4 2022

Jan 17, 2023
BUY
$321.55 - $374.67 $21,222 - $24,728
66 Added 2.42%
2,793 $0
Q3 2022

Oct 17, 2022
SELL
$296.48 - $337.87 $5,929 - $6,757
-20 Reduced 0.73%
2,727 $881,000
Q2 2022

Jul 15, 2022
BUY
$278.73 - $327.27 $5,574 - $6,545
20 Added 0.73%
2,747 $891,000
Q1 2022

May 05, 2022
BUY
$234.69 - $291.66 $19,009 - $23,624
81 Added 3.06%
2,727 $781,000
Q4 2021

Jan 27, 2022
SELL
$224.85 - $279.04 $22,934 - $28,462
-102 Reduced 3.71%
2,646 $730,000
Q3 2021

Oct 25, 2021
SELL
$221.6 - $272.71 $44,098 - $54,269
-199 Reduced 6.75%
2,748 $635,000
Q2 2021

Aug 02, 2021
BUY
$180.55 - $233.54 $68,428 - $88,511
379 Added 14.76%
2,947 $676,000
Q1 2021

May 25, 2021
SELL
$164.32 - $212.72 $19,225 - $24,888
-117 Reduced 4.36%
2,568 $480,000
Q4 2020

Feb 08, 2021
BUY
$130.46 - $172.63 $156,552 - $207,156
1,200 Added 80.81%
2,685 $453,000
Q3 2020

Nov 02, 2020
BUY
$146.22 - $169.13 $11,990 - $13,868
82 Added 5.84%
1,485 $219,000
Q2 2020

Aug 07, 2020
BUY
$136.42 - $164.18 $191,397 - $230,344
1,403 New
1,403 $214,000
Q1 2019

May 10, 2019
SELL
$111.31 - $131.02 $297,976 - $350,740
-2,677 Closed
0 $0
Q4 2018

Feb 06, 2019
BUY
$105.9 - $118.64 $42,360 - $47,456
400 Added 17.57%
2,677 $309,000
Q3 2018

Nov 13, 2018
SELL
$85.86 - $107.31 $85,860 - $107,310
-1,000 Reduced 30.52%
2,277 $244,000
Q3 2017

Nov 14, 2017
SELL
$77.07 - $85.54 $17,803 - $19,759
-231 Reduced 6.58%
3,277 $280,000
Q2 2017

Aug 09, 2017
BUY
N/A
3,508
3,508 $289,000

Others Institutions Holding LLY

# of Institutions
3,721
Shares Held
738M
Call Options Held
7.09M
Put Options Held
7.24M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Advisors Inc Portfolio

Follow Capital Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email